Recipharm Expands Blow-Fill-Seal Capacity at France Facility
PTSM: Pharmaceutical Technology Sourcing and Management
The company will invest €18 million in its Kaysersberg facility to expand blow-fill-seal capacity.
On July 5, 2016, Recipharm announced that the company will invest €18 million (approximately $19.73) to expand blow-fill-seal (BFS) capacity at its site in Kaysersberg, France. The investment will include the introduction of a BFS high-speed filling and packaging line, Recipharm said in a press announcement. Recihparm’s Kaysersberg site is a sterile facility specializing in BFS technology for sterile liquids.
Recipharm says it will also prepare to add three additional filling lines to the facility in upcoming years, increasing the company’s BFS capacity by 50%. Yves Buelens, general manager of the Kaysersberg site, said the company is experiencing increased demand for BFS services. “We are experiencing increased demand for our blow-fill-seal services from markets including the United States, Turkey, Australia, and Canada, and the new filling line will help us to meet this growing need,” Buelens noted in a press announcement.
Source: Recipharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
